Clinical trials
Terminated Phase 3 Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 1 |
| 2011 | 5 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 4 |
| Takeda | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Eli Lilly and Company | 2 |
| Amgen | 1 |
| Drug Commission of the German Medical Association | 1 |
| Karo Bio AB | 1 |
| Organon and Co | 1 |
| Pfizer | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 22 |
| Dyslipidemias | 5 |
| Hyperlipidemias | 5 |
| Coronary Artery Disease | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Thyroid Diseases | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.